Gujarat Themis Biosyn Share price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 6,11,469 shares, with a market capitalization of ₹108965265. Its Average Traded Price (ATP) is ₹419.58, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 8 @ ₹420.50.
Gujarat Themis Biosyn has an upper circuit limit of ₹485.60 and a lower circuit limit of ₹323.80. The total value traded stands at ₹25.66 CR, and the delivery percentage for the day is 49.02%.
The stock is currently traded with a market lot size of 1. Gujarat Themis Biosyn also offers a dividend yield of 0.16%.
Gujarat Themis Biosyn share price chart
Gujarat Themis Biosyn Share Key Metrics
Volume
6.11 L
Market Cap
4409.82 CR
LTQ@LTP
8@420.50
ATP
419.58
Var Margin
25.02 %
Circuit Range
323.8-485.6
Delivery %
49.02 %
Value
25.66 CR
ASM/GSM
No
Market Lot
1
Gujarat Themis Biosyn Resistance and Support
Pivot 404.45
Resistance
First Resistance
416.9
Second Resistance
429.1
Third Resistance
441.55
Support
First Support
392.25
Second Support
379.8
Third Support
367.6
Gujarat Themis Biosyn Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Gujarat Themis Biosyn Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results |
| 2026-06-19 | To consider Fund Raising |
| 2026-06-06 | Fund Raising & Others |
| 2026-05-25 | Audited Results |
| 2026-02-05 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2025-09-04 | 2025-09-05 | View More |
| Bonus Date | Record Date | |
|---|---|---|
| 2024-05-14 | 2024-08-09 | View More |
Gujarat Themis Biosyn News
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Outcome for Outcome Of Board Meeting Related To QIP
Gujarat Themis Biosyn Board approved a Qualified Institutional Placement (QIP) of equity shares to Qualified Institutional Buyers (QIBs). The floor price for the QIP has been fixed at ₹372.57 per share, with a potential discount of up to 5%.
Aug 25 2026 23:29:28
Gujarat Themis Biosyn Ltd - 506879 - Announcement Under Reg 30 (LODR) - Updates (Audited Financial Statements)
Gujarat Themis Biosyn disclosed two significant acquisitions post FY26: an asset purchase agreement for anti-TB and anti-infective brands from Sanofi for EUR 158 million, and 100% equity in MicroBiopharm Japan for JPY 21.5 billion. These deals, totaling over Rs.2,700 crore, aim to strengthen the company's product portfolio and market presence, with completion expected by Dec 2026 and Q2 FY27 respectively.
Aug 25 2026 21:34:30
Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Gujarat Themis Biosyn shareholders approved an amendment to the Articles of Association through a Postal Ballot. This change removes the requirement for a valuation report when shares are transferred for cash or other consideration.
Aug 23 2026 15:47:48
Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Gujarat Themis Biosyn shareholders passed a special resolution to amend Article 13(1)(c) of its Articles of Association. This amendment removes the clause requiring a registered valuer's report for determining the price of shares issued for cash or other consideration, simplifying future share issuance procedures.
Aug 23 2026 12:24:41
Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Gujarat Themis shareholders approved special resolutions for capital raising through Qualified Institutions Placement and private placement of NCDs. These measures, passed with over 99.97% approval, enhance the company's financial flexibility.
Aug 22 2026 19:03:23
Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Gujarat Themis shareholders approved special resolutions for capital raising through Qualified Institutions Placement and private placement of NCDs. These measures, passed with over 99.97% approval, enhance the company's financial flexibility.
Aug 22 2026 19:00:29
Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Gujarat Themis Biosyn's EGM on August 22, 2026, approved resolutions including the private placement of non-convertible debentures (NCDs) or other debt securities and material related party transactions with promoter entities. Amendments to the Articles of Association were also approved, providing financial flexibility and governance updates for the company.
Aug 22 2026 18:08:02
Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Outcome of EGM
Gujarat Themis Biosyn shareholders approved material related party transactions and authorized the private placement of non-convertible debentures and/or debt securities at its EGM. These approvals pave the way for potential future fundraising and inter-company dealings.
Aug 22 2026 16:17:59
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.08.2026
Gujarat Themis Biosyn board approved Q1 FY27 financial results. Revenue increased 22.07% YoY to ₹43.79 cr, and net profit rose 22.12% YoY to ₹11.07 cr. The company also incorporated two wholly-owned subsidiaries in Japan and Ireland during the quarter.
Aug 07 2026 12:58:47
Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Gujarat Themis Biosyn has scheduled an Extra-Ordinary General Meeting (EGM) on August 22, 2026. Shareholders will consider and approve resolutions for a private placement of non-convertible debt securities, material related party transactions with promoter/promoter group entities, and amendments to the Articles of Association.
Aug 02 2026 00:32:42
Gujarat Themis Biosyn Management
| Name | Position |
|---|---|
| Vineet G Gawankar | Company Secretary & Compliance Officer |
| Dinesh S Patel | Chairman |
Gujarat Themis Biosyn Similar Stocks
Gujarat Themis Biosyn FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GUJTHEM
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC